Can a shingles vaccine and diabetes drug save insulin cells?

NCT ID NCT07614412

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether the shingles vaccine Shingrix and the diabetes drug semaglutide, alone or together, can help preserve the body's ability to make insulin in adults recently diagnosed with type 1 diabetes. The goal is to slow the immune attack on insulin-producing cells and protect them from damage. About 240 adults aged 18 to 50 who were diagnosed within the last 100 days will take part. The main measure is how well the pancreas responds to a meal test after one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECENT-ONSET TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ministry of Health Medical City

    Riyadh, Saudi Arabia

More trials for these conditions

Other studies related to the condition(s) this trial covers.